
样式: 排序: IF: - GO 导出 标记为已读
-
Prevalence of Suicidal Ideation and Suicide Attempts by Race and Gender in Three Large U.S. Adolescent Cohorts. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-28
Ashley M Cooper,Elina Visoki,Kate T Tran,Ezer Elbaz,Mārtiņš M Gataviņš,Sarah McKetta,Joel A Fein,Tami D Benton,Ran Barzilay -
Self-Control Abilities in Specific Types of Problematic Usage of the Internet: Findings From Clinically Validated Samples With Neurocognitive Tasks. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-28
Silke M Müller,Stephanie Antons,Anna M Schmid,Tobias A Thomas,Annica Kessling,Maithilee Joshi,Kseniya Krikova,Miriam Kampa,Lukas Mallon,Lasse David Schmidt,Lena Klein,Nanne Dominick,Kjell Büsche,Andreas Oelker,Annika Brandtner,Christian Montag,Klaus Wölfling,Oliver T Wolf,Martin Diers,Tim Klucken,Hans-Jürgen Rumpf,Rudolf Stark,Astrid Müller,Elisa Wegmann,Sabine Steins-Loeber,Matthias BrandOBJECTIVE Reduced cognitive functions are commonly associated with diminished self-control abilities. Research on cognitive functions in gaming disorder and other specific types of problematic usage of the Internet (PUI) remains rare. The aim of this study was to compare performance in different cognitive domains between clinically validated groups of individuals with and without specific PUI. METHODS
-
Impact of Polygenic Interactions With Anticholinergic Burden on Cognition and Brain Structure in Psychosis Spectrum Disorders. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-28
Lusi Zhang,Elena I Ivleva,David A Parker,Scot K Hill,Paulo L Lizano,Richard S E Keefe,Sarah K Keedy,Jennifer E McDowell,Godfrey D Pearlson,Brett A Clementz,Matcheri S Keshavan,Elliot S Gershon,Carol A Tamminga,John A Sweeney,Jeffrey R BishopOBJECTIVE The authors sought to determine whether genetic predispositions to cognitive ability or psychiatric conditions interact with anticholinergic burden (AChB) to impact cognition and brain structure in individuals with psychotic disorders. METHODS Participants with psychosis spectrum disorders (N=1,704) from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) consortium, 18-65
-
National Trends in Suicidal Thoughts and Suicide Attempts Among High School Students in the United States. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-28
Tanner J Bommersbach,Mark Olfson,Taeho Greg RheeOBJECTIVE The authors sought to estimate national trends in suicidal thoughts and attempts among high school students with and without health-risk behaviors. METHODS Data were analyzed from the 2007 to 2021 Youth Risk Behavior Survey, a biennial cross-sectional survey of U.S. high school students (unweighted sample, N=119,654). Suicidal thoughts were defined as seriously considering attempting suicide
-
Prospective Associations Between Structural Brain Development and Onset of Depressive Disorder During Adolescence and Emerging Adulthood. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-07
Sarah Whittle,Divyangana Rakesh,Julian G Simmons,Orli Schwartz,Nandita Vijayakumar,Nicholas B AllenOBJECTIVE Brain structural alterations are consistently reported in depressive disorders, yet it remains unclear whether these alterations exist prior to disorder onset and thus may reflect a preexisting vulnerability. The authors investigated prospective adolescent neurodevelopmental risk markers for depressive disorder onset, using data from a 15-year longitudinal study. METHODS A community sample
-
Relationship Between Problematic Alcohol Use and Various Psychiatric Disorders: A Genetically Informed Study. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-07
Yeeun Ahn,Jaehyun Kim,Kyeongmin Jung,Dong June Lee,Jin Young Jung,Yewon Eom,Sanghyeon Park,Jaeyoung Kim,Hyejin Kim,Hyeonbin Jo,Sanghoon Hong,Kevin S O'Connell,Ole A Andreassen,Woojae Myung,Hong-Hee WonOBJECTIVE Problematic alcohol use (PAU) adversely affects the clinical course of psychiatric disorders. Genetic studies have suggested that genetic factors underlie the co-occurrence of PAU with psychiatric disorders. This study aimed to elucidate shared genetic architectures, prioritizing genes that disorders may have in common. METHODS Using genome-wide association data of PAU including 435,563 samples
-
Advancing an Inflammatory Subtype of Major Depression. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-07
Andrew H MillerChronic inflammation plays a prominent role in multiple medical disorders, including psychiatric diseases such as major depression. Exposure to inflammatory stimuli leads to changes in neurotransmitter systems and neurocircuits in the brain that are associated with depressive symptoms. Blockade of inflammatory cytokines can reduce depressive symptoms in medically ill and medically healthy individuals
-
Psychotherapy Trends in the United States. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Mark Olfson,Chandler McClellan,Samuel H Zuvekas,Melanie Wall,Carlos BlancoOBJECTIVE The authors investigated recent national trends in outpatient mental health care and psychotherapy. METHOD Service data from four representative surveys of the U.S. household population, the 2018-2021 Medical Expenditure Panel Survey, were analyzed focusing on adults with outpatient mental health visits (N=17,821) including psychotherapy visits (N=6,415). The authors present trends in age
-
Beyond Either/Or: The Next Chapter in PTSD and Alcohol Use Disorder Treatment Research. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Denise Nguyen Hien,Teresa Lopez-Castro -
Randomized Controlled Trial of "Bounce Back Now," a Mobile App to Reduce Post-Disaster Symptoms of Posttraumatic Stress, Depressed Mood, and Sleep Disturbance. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Kenneth J Ruggiero,Arthur Andrews,Tatiana M Davidson,Yulia Gavrilova,Brian E Bunnell,Jennifer Dahne,Matthew Price,Zoe M F Brier,Gregory Cohen,Dean Kilpatrick,Ron Acierno,Sandro GaleaOBJECTIVE There is tremendous public health interest in cost-efficient, scalable interventions to improve post-disaster mental health. The authors examined the efficacy of Bounce Back Now (BBN), a mobile application, versus an enhanced usual care app (EUC). METHODS A population-based trial was conducted with a diverse sample of 1,357 adults affected by Hurricane Harvey, Irma, Maria, Florence, or Michael
-
Diverse Treatment Strategies and the Valuable Work That Brings Them Forward. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Ned H Kalin -
Problems With Noninferiority Designs in PTSD Treatment Research: Losing Signal to Noise. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Sheila A M Rauch,H Myra Kim,Ron Acierno,Peter W Tuerk,Barbara O Rothbaum -
Harnessing Technology to Reimagine and Scale Support for Individual and Community Mental Health After Disaster. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Shannon Wiltsey Stirman,Adrienne Heinz -
Neuropsychiatric Symptoms of Subacute and Chronic Long COVID. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Thida M Thant,Abhisek C Khandai,Aisha Gillan,Melissa Peace,Davin Quinn,John Levenson -
An Update on Psychotherapy for the Treatment of PTSD. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Barbara Olasov Rothbaum,Laura E WatkinsPosttraumatic stress disorder (PTSD) symptoms are part of the normal response to trauma. Most trauma survivors will recover over time without intervention, but a significant minority will develop chronic PTSD, which is unlikely to remit without intervention. Currently, only two medications, sertraline and paroxetine, are approved by the U.S. Food and Drug Administration to treat PTSD, and the combination
-
Can Two 90-Minute Workshops Reduce Risk of Substance Use Disorder for Vulnerable Seventh Graders? Results and Scalability From the Co-Venture Trial. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Brooke S G Molina -
Telemental Health Care for Children and Adolescents in the United States: Challenges and Opportunities. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-05-01
Barbara J Coffey -
Treating Depression With Repetitive Transcranial Magnetic Stimulation: A Clinician's Guide. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-30
Leo Chen,Andrew M Fukuda,Shixie Jiang,Michael K Leuchter,Sanne J H van Rooij,Alik S Widge,William M McDonald,Linda L CarpenterTranscranial magnetic stimulation (TMS) applies electromagnetic pulses to stimulate cortical neurons. The antidepressant effect of the repetitive application of TMS (rTMS) was first shown nearly three decades ago. The therapeutic potential of TMS has been extensively investigated, mostly in treatment-resistant depression (TRD). Studies have extensively evaluated stimulation parameters, treatment schedules
-
Systemic Inflammation and Anhedonic Responses to an Inflammatory Challenge in Adults With Major Depressive Disorder: A Randomized Controlled Trial. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-23
Jonathan Savitz,Leandra K Figueroa-Hall,T Kent Teague,Hung-Wen Yeh,Haixia Zheng,Rayus Kuplicki,Kaiping Burrows,Nour El-Sabbagh,MacGregor Thomas,Isaac Ewers,Yoon-Hee Cha,Salvador Guinjoan,Sahib S Khalsa,Martin P Paulus,Michael R IrwinOBJECTIVE The authors sought to determine whether an inflammatory challenge with lipopolysaccharide (LPS) differentially impacts symptoms of anhedonia in participants with major depressive disorder with high (≥3 mg/L) and low (≤1.5 mg/L) serum C-reactive protein (CRP) concentrations. METHODS Sixty-eight participants with major depressive disorder were randomly assigned, in a 1:1 ratio, to receive LPS
-
Long-Read Genome Sequencing in Clinical Psychiatry: RFX3 Haploinsufficiency in a Hospitalized Adolescent With Autism, Intellectual Disability, and Behavioral Decompensation. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-09
Milad Mortazavi,Sergey Batalov,Jerica Lenberg,Corrine Blucher,Aisha Omorodion,Daniel Helbling,Lucita Van Der Kraan,Zaira Bezares-Orin,Arivudainambi Ramalingam,Matthew N Bainbridge,Jonathan Sebat,Aaron D Besterman -
Trends in Prescription Stimulant, Opioid, and Benzodiazepine Use and Diversion in U.S. Adolescents. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-09
Sean Esteban McCabe,Emily Pasman,Timothy E Wilens,Ty S Schepis,Vita V McCabe,Jason A Ford,John Jardine,Philip T Veliz -
Variability Rather Than Means? Harnessing the Adversary to Advance Precision Psychiatry. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-01
Raquel E Gur,David R Roalf,Daniel H Wolf,Ruben C Gur -
Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in Schizophrenia. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-01
Funda Orhan,Susmita Malwade,Neda Khanlarkhani,Asimenia Gkogka,Angelika Langeder,Oscar Jungholm,Marja Koskuvi,Šárka Lehtonen,Lilly Schwieler,Kent Jardemark,Jari Tiihonen,Jari Koistinaho,Sophie Erhardt,Göran Engberg,Samudyata Samudyata,Carl M SellgrenOBJECTIVE Schizophrenia is a neurodevelopmental disorder characterized by an excessive loss of synapses. Kynurenic acid (KYNA), a neuroactive metabolite of tryptophan along the kynurenine pathway, can induce schizophrenia-related phenotypes in rodents, and clinical studies have revealed elevated KYNA levels in the CNS of individuals with schizophrenia. However, the factors that cause elevated KYNA
-
A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-01
K N Roy Chengappa,Jessica M Gannon,Yash B Joshi -
What Do Four Decades of Research Tell Us About the Association Between Childhood Adversity and Psychosis: An Updated and Extended Multi-Level Meta-Analysis. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-01
Lan Zhou,Iris E C Sommer,Pengyuan Yang,Lev Sikirin,Jim van Os,Richard P Bentall,Filippo Varese,Marieke J H BegemannOBJECTIVE Estimating the current association between childhood adversity and the risk of psychosis is crucial for prevention and intervention. We provided an updated synthesis of evidence from the past four decades, expanded the available data by investigating a broad array of adversity subtypes, and explored sex differences and the age of psychosis onset as relevant factors. METHODS We searched PubMed
-
Psychotic Disorders and Schizophrenia: Treatment, Risk, Brain Alterations, and Mechanisms. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-01
Ned H Kalin -
When the Bow Breaks: Are We Ever Going to Prevent Childhood Adversity? Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-01
C Neill Epperson -
Long-Term Antipsychotic Use and the Benefit-to-Harm Balance: More on the Risk of Relapse. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-01
Robin Emsley -
An Update on the Use of Neuromodulation Strategies in the Treatment of Schizophrenia. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-04-01
Nicholas H Neufeld,Daniel M BlumbergerThe field of neuromodulation has evolved tremendously and now includes a vast array of interventions utilizing different technologies that span electrical, magnetic, and ultrasound forms of stimulation. The evolution of interventions holds the promise of fewer adverse effects and a noninvasive approach, increasing the scale at which these interventions may be offered in hospital and community settings
-
20 Years of Aberrant Salience in Psychosis: What Have We Learned? Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-26
Philip R Corlett,Kurt M FraserTwenty years ago Shitij Kapur's "Psychosis as a state of aberrant salience" captured the attention of clinicians and cognitive and behavioral neuroscientists. It has become the de facto way of talking about delusion formation in labs and clinics. Here, evidence for this theory is critically evaluated in consideration of evolving data since its publication. A particular focus is placed on its specific
-
A Call to Action: Evidence-Based Contingency Management. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-26
Carla J Rash,Michael McDonell,Tyler Erath,Sara Parent,Richard Rawson,Sarah Wattenberg -
Psychiatric Genetics in Clinical Practice: Essential Knowledge for Mental Health Professionals. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-26
Aaron D Besterman,Mohamed A Alnor,Mauricio Castaño,Lynn E DeLisi,Dorothy E Grice,Falk W Lohoff,Christel M Middeldorp,Daniel J Müller,Diego Quattrone,John Nurnberger,Erika L Nurmi,David A Ross,Takahiro Soda,Thomas G Schulze,Brett Trost,Elisabet Vilella,Chloe X Yap,Gwyneth Zai,Daniel Moreno-De-LucaOBJECTIVE The authors provide recommendations on incorporating recent advances in psychiatric genetics into clinical practice for mental health clinicians. METHOD The International Society for Psychiatric Genetics Education Committee met monthly to come to a consensus on priority topics in psychiatric genetics. Topics were then assigned to small teams of subspecialty experts to summarize the current
-
High-Potency Cannabis Use and Health: A Systematic Review of Observational and Experimental Studies. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-26
Stephanie Lake,Conor H Murray,Brittany Henry,Liza Strong,Kendall White,Beau Kilmer,Ziva D CooperOBJECTIVE Amid continuously rising concentrations of delta-9-tetrahydrocannabinol (THC) in cannabis (i.e., potency), high-potency cannabis is a major topic in contemporary cannabis policy discussions, yet its impact on health is not well understood. The authors conducted a systematic review of observational and experimental studies examining the relationship between high-potency cannabis use and a
-
A Randomized Clinical Trial of Prolonged Exposure Therapy With and Without Topiramate for Comorbid PTSD and Alcohol Use Disorder. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-19
Sonya B Norman,Matthew T Luciano,Kaitlyn E Panza,Brittany C Davis,Michelle Lyons,Brian Martis,Scott C Matthews,Abigail C Angkaw,Moira Haller,Katharine Lacefield,Arthur L Brody,Paula P Schnurr,Steven L Batki,Tracy L Simpson,Robert M AnthenelliOBJECTIVE Posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) frequently co-occur. Prolonged exposure (PE) is an effective treatment for PTSD but shows smaller effects in patients with co-occurring AUD. Topiramate may help reduce alcohol use and PTSD symptoms. This double-blind, placebo-controlled outpatient clinical trial compared 12 sessions of PE plus either topiramate or placebo
-
Assessment and Management of Concurrent Substance Use in Patients Receiving Repetitive Transcranial Magnetic Stimulation for Depressive, Obsessive-Compulsive, Psychotic, and Trauma-Related Disorders: A Delphi Consensus Study and Guideline. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-19
Victor M Tang,Scott Aaronson,Mohamed Abdelghani,Chris Baeken,Tracy Barbour,André R Brunoni,Samuel Bulteau,Linda L Carpenter,Paul E Croarkin,Zafiris J Daskalakis,Paul B Fitzgerald,F Andrew Kozel,Bernard Le Foll,Urvakhsh Meherwan Mehta,Yoshihiro Noda,Frank Padberg,Christian Plewnia,Hang Su,Philip van Eijndhoven,Eric van Exel,Iris van Oostrom,Fidel Vila-Rodriguez,Daphne Voineskos,Saydra Wilson,DanielOBJECTIVE Limited data are available to inform clinicians on how to manage concurrent substance use in the context of repetitive transcranial magnetic stimulation (rTMS) for the treatment of depressive, obsessive-compulsive, psychotic, or trauma-related disorders. The authors convened an international panel of 24 rTMS experts, representative of different geographic regions and subspecialities, and
-
Six Years After Approval of Esketamine Nasal Spray for Serious Depression: Clinical Conundrums and Unanswered Questions. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-01
Sanjay J Mathew,Nicholas Murphy -
Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-01
Metten Somers,Floortje E Scheepers -
New Developments in the Treatment of Depression, OCD, and Schizophrenia. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-01
Ned H Kalin -
Beyond Feared Outcomes: Exploring Sensory Phenomena as a Novel Therapeutic Target for OCD. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-01
Dana E Díaz,Kate D Fitzgerald -
Pharmaco-Transcranial Magnetic Stimulation: Letting Mechanism Guide the Way. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-01
Joshua C Brown,Noah S Philip -
Spaced Transcranial Direct Current Stimulation for Depression: The Road Less Traveled. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-01
Andre R Brunoni,Frank Padberg -
Xanomeline-Trospium Treatment of Cognitive Impairments of Schizophrenia: Hope for Some, or Hope for All? Am. J. Psychiatry (IF 15.1) Pub Date : 2025-03-01
Daniel C Javitt -
Anticholinergic Burden and Cognitive Function in Psychosis: A Systematic Review and Meta-Analysis. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-26
Valentina Mancini,Caren Latreche,Jack B Fanshawe,Ioana Varvari,Chambrez-Zita Zauchenberger,Nova McGinn,Ana Catalan,Toby Pillinger,Philip K McGuire,Robert A McCutcheonOBJECTIVE The authors synthesized evidence from studies quantifying the relationship between anticholinergic medication and cognitive function in psychosis, and additionally explored studies that investigated whether reducing anticholinergic medications affects cognitive function in individuals with psychosis. METHODS A database search was conducted in MEDLINE, Embase, and PsycINFO, from database inception
-
Intermittent Theta Burst Stimulation With Adjunctive D-Cycloserine for Obsessive-Compulsive Disorder: A Randomized Clinical Trial. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-19
Alexander McGirr,Jaeden Cole,Scott B Patten,Beverly Adams -
Continuous Dopamine D2 Receptor Blockade and Long-Term Outcome in First-Episode Schizophrenia. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-19
Jari Tiihonen,Antti Tanskanen,Marco Solmi,Jose M Rubio,Christoph U Correll,John M Kane,Heidi TaipaleOBJECTIVE It is not known what proportion of patients experience relapse in first-episode schizophrenia despite continuous dopamine D2 receptor blockade and whether breakthrough psychosis is attributable to long-term use of D2-blocking antipsychotics. Using data from a Finnish nationwide cohort, the authors sought to test the hypothesis that the incidence of breakthrough psychosis is accelerated among
-
Tobacco, Alcohol, Heroin, Binge Eating, and Behavioral Addictions. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-01
Ned H Kalin -
Prospective Associations Between Tobacco Product Use and Mental Health and Substance Use Problems Among U.S. Adolescents and Adults. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-01
Kevin P Conway,Emmanuella Michel,Sam Eig,Jian-Ping He,Kathleen R MerikangasOBJECTIVE The authors examined prospective associations between tobacco product use and mental health and substance use problems among U.S. adolescents and adults. METHODS Covariate-adjusted models using discrete-time survival analysis of five annual waves (2013-2014 to 2018-2019) were used to examine the links between specific tobacco product use and mental health and substance use problems among
-
Tobacco Use Is Associated With Mental Illness and Substance Use Problems-Now What? Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-01
Judith J Prochaska -
Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-01
Andrea C King,Andrew M Fischer,John F Cursio,Nathan A Didier,Zoe Lee,Daniel J FridbergOBJECTIVE The allostasis theory states that, as addiction develops, alcohol is consumed to relieve negative affect rather than to produce positive effects. This study aimed to investigate the real-time subjective effects of alcohol in individuals with alcohol use disorder (AUD) and those prone to negative affect by virtue of having comorbid depressive disorder (DEP). METHODS Participants (N=221) completed
-
Understanding the Effects of Combined Lisdexamfetamine and Cognitive Behavior Therapy for Adults With Binge Eating Disorder. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-01
Tom Hildebrandt,Elizabeth Martin -
Using Genetically Diverse Rats to Identify Individual Differences in Addiction-Related Behaviors and Brain Activity. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-01
Ginevra D'Ottavio,Kenichiro Negishi,Yavin Shaham -
Varenicline as a First-Line Treatment for Individuals With Current Major Depressive Disorder Who Smoke Cigarettes. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-01
Andrea H Weinberger,Marc L Steinberg -
Correcting Overestimations in Self-Harm Visit Data. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-01
Abid Rizvi -
Correcting Overestimations in Self-Harm Visit Data: Response From Bommersbach and Colleagues. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-01
Tanner J Bommersbach,Mark Olfson,Taeho Greg Rhee -
A Fresh Look at the Allostasis Theory of Addiction. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-02-01
Markus Heilig -
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-01-29
Konstantinos N Fountoulakis,Athanasios Saitis,Alan F SchatzbergOBJECTIVE Intranasal esketamine has been approved as an adjunctive therapy for treatment-resistant major depressive disorder with acute suicidal ideation and behavior. The authors conducted a systematic review and meta-analysis of the available data on its efficacy against depression and suicidality as well as its side effects. METHODS MEDLINE was searched with the keyword "esketamine" on March 24
-
Spaced Transcranial Direct Current Stimulation for Major Depression. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-01-29
Maxime Couture,Véronique Desbeaumes Jodoin,Emma Bousseau,Arash Sarshoghi,Michael A Nitsche,Daniel M Blumberger,Chantal Bolduc,Cory R Weissman,Lawrence G Appelbaum,Zafiris J Daskalakis,Mohsen Poorganji,Paul Lespérance,Jean-Philippe MironOBJECTIVE This study investigated spaced transcranial direct current stimulation for major depressive disorder, focusing on feasibility. METHODS In a prospective open-label study, 30 participants with major depressive disorder were enrolled to receive a 50-session transcranial direct current stimulation (tDCS) treatment over 2 weeks. The feasibility, safety, tolerability, and preliminary therapeutic
-
Randomized Controlled Trial of the Effects of High-Dose Ondansetron on Clinical Symptoms and Brain Connectivity in Obsessive-Compulsive and Tic Disorders. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-01-29
Emily R Stern,Katherine A Collins,Laura B Bragdon,Goi Khia Eng,Nicolette Recchia,Barbara J Coffey,Evan Leibu,James W Murrough,Russell H Tobe,Dan V Iosifescu,Katherine E Burdick,Wayne K GoodmanOBJECTIVE Sensory phenomena (SP) are aversive sensations driving repetitive behaviors in obsessive-compulsive disorder (OCD) and Tourette's disorder that are not well addressed by standard treatments. SP are related to the functioning of an interoceptive-sensorimotor circuit that may be modulated by the 5-HT3 receptor antagonist ondansetron. The present study employed an experimental medicine approach
-
Use of Telemental Health Care by Children and Adolescents in the United States. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-01-15
Mark Olfson,Chandler McClellan,Samuel H Zuvekas,Melanie Wall,Carlos Blanco -
Distinct Behavioral Profiles and Neuronal Correlates of Heroin Vulnerability Versus Resiliency in a Multi-Symptomatic Model of Heroin Use Disorder in Rats. Am. J. Psychiatry (IF 15.1) Pub Date : 2025-01-15
Brittany N Kuhn,Nazzareno Cannella,Ayteria D Crow,Veronica Lunerti,Arkobrato Gupta,Stephen J Walterhouse,Carter Allen,Reda M Chalhoub,Eric Dereschewitz,Analyse T Roberts,Mackenzie Cockerham,Angela Beeson,Rusty W Nall,Abraham A Palmer,Gary Hardiman,Leah C Solberg Woods,Dongjun Chung,Roberto Ciccocioppo,Peter W KalivasOBJECTIVE The behavioral and diagnostic heterogeneity within the opioid use disorder (OUD) diagnosis is not readily captured in current animal models, limiting the translational relevance of the mechanistic research that is conducted in experimental animals. The authors hypothesized that a nonlinear clustering of OUD-like behavioral traits would capture population heterogeneity and yield subpopulations